In my role as Director of Evidence at MSI, I manage a team of 12 analysts, reserachers and HMIS leads supporting evidence generation across MSI's 37 country programmes. I also oversee our portfolio of formative, operational and clinical research projects. MSI conducts studies to understand how to increase the scale of its family planning and abortion programmes, to improve their quality, and to ensure their sustainability.  Our team supports studies on post-abortion family planning, task-sharing for contraceptive and/or abortion provision (including to community health workers and pharmacists), quality of care, reaching marginalised or vulnerable groups, and promoting the high quality provision of long-acting and permanent methods of contraception. I help assure the quality of quantitative and qualitative research conducted across MSI's country programmes in Africa and Asia, and support dissemination and reporting of findings. 

In my previous roles at LSHTM, I conducted research for the ALPHA network, analysing HIV policies and their implementation in services access across 6 sub-Saharan countries; and for the Integra Initiative, a multi-country study investigating the integration of SRH and HIV services, and a partnership between LSHTM, Population Council and the International Planned Parenthood Federation. My PhD, which formed one sub-study within Integra, was an in-depth case study comparing four different models of HIV care and treatment (stand-alone and integrated SRH-HIV services) in Swaziland. Areas of focus were contraceptive needs and practices among people living with HIV, use of integrated services, satisfaction with care, and perceptions of HIV-related stigma. The study utilised mixed quantitative and qualitative methodologies.